hsa-miR-221

ncRNA information

ncRNA name

hsa-miR-221

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

TIMP3

Cancer information

Cancer name

Oral Squamous Cell Carcinoma

Cancer site

Lip, Oral Cavity

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

These results indicated that OSCC cells are resistant to doxorubicin through upregulation of miR-221.

Tissue resource

oral squamous cell carcinoma cell lines SCC4

oral squamous cell carcinoma cell lines SCC9

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the Beijing Institute for Cancer Research

Country

China

Continent

Asia